A surreal maze illustrates the complexities of Medicaid funding paths.

The Affordable Care Act's Hidden Flaw: Are States Gaming the System?

"New research uncovers how states may be inflating Medicaid expansion costs, impacting healthcare budgets nationwide."


The Affordable Care Act (ACA), enacted in 2010, brought about significant changes to the healthcare landscape in the United States, most notably through the expansion of Medicaid. Medicaid, the single largest source of health insurance in the U.S., covers approximately 85 million Americans, with an annual cost of around $750 billion, funded by both the federal government and individual states. The ACA allowed states to expand Medicaid eligibility to non-elderly adults with incomes up to 138% of the federal poverty level, with the federal government initially covering 100% of the costs for these newly eligible enrollees, later decreasing to 90% in perpetuity.

A recent study sheds light on a potentially problematic aspect of this expansion: a fiscal incentive that may have led states to reclassify existing Medicaid enrollees into the 'newly eligible' category. Under the ACA, the federal government pays a substantially larger share of medical costs for newly eligible enrollees compared to those previously eligible. This creates an opportunity for states to save money—potentially up to 100% of per-enrollee costs—by strategically reclassifying enrollees.

The research suggests that Medicaid expansion has led to a decline in the number of beneficiaries enrolled in the original Medicaid population, implying widespread reclassification. In 2019 alone, this phenomenon affected an estimated 4.4 million Medicaid enrollees, costing the federal government $8.3 billion. These reclassifications may have inflated the federal cost of Medicaid expansion by 18.2%. This article examines this hidden subsidy, its implications, and the potential responses to ensure the integrity of Medicaid funding.

AI Search Multiple angles on this topic

Expansion Numbers Are Hard to Pin Down

Precise enrollment and spending figures for the Affordable Care Act's Medicaid expansion are difficult to capture in a single statistic, in large part because each state administers its own program and reports data on different schedules. Early expansion states saw sharp increases in Medicaid rolls, while states that declined to expand left significant numbers of low-income adults without newly available coverage. Analysts continue to debate how much of recent enrollment growth reflects genuine need versus states' strategic use of program flexibility. Given the variation in state reporting, any headline number should be treated as an approximation rather than a settled figure.

A Joint Federal-State Framework

Medicaid is a joint federal-state program that provides health coverage to eligible low-income adults, children, pregnant women, the elderly, and people with disabilities, with states administering the program according to federal requirements. Because it is funded jointly by state and federal governments, the partnership is central to how Affordable Care Act expansion works in practice. Federal baseline standards constrain how states operate, yet states also retain wide latitude in determining eligibility and benefits, which is precisely the flexibility that raises questions about how expansion rules are applied. Eligible individuals can learn how to apply and find coverage through official public channels such as Medicaid.gov and USAGov, but the accepted analytical approach of comparing federal standards against state implementation is limited by the fact that eligibility rules and reported data vary considerably from state to state.

Roots in Federal-State Coproduction

The modern Medicaid program grew out of a long-standing arrangement in which Washington sets broad baseline standards while individual states design and run their own programs. Over time, major federal initiatives layered new coverage opportunities onto that structure, and the Affordable Care Act's expansion followed the same pattern by offering enhanced federal funding in exchange for state participation. That voluntary, state-driven design is widely regarded as the historical foundation of the debates examined here, because it institutionalized wide variation in who, what, and how much each state covers. Because the program's history is characterized by shifting rules and ambitions, any milestone discussion is necessarily shaped by the source consulted and should be treated as approximate.

What is Medicaid Reclassification and Why Does It Matter?

A surreal maze illustrates the complexities of Medicaid funding paths.

Medicaid reclassification, in this context, refers to states shifting existing Medicaid enrollees—those who would have been eligible for Medicaid before the ACA—into the 'newly eligible' expansion group. Since the federal government provides a higher matching rate for this expansion group, states can effectively offload a greater portion of their Medicaid costs to the federal government. This creates a strong fiscal incentive for states to engage in reclassification, whether deliberately or through administrative loopholes.

The implications of this practice are far-reaching. While reclassification itself may not directly affect the coverage or benefits received by Medicaid enrollees, it has significant fiscal consequences for both states and the federal government. By inflating the number of enrollees in the expansion group, states can draw down more federal funds, potentially at the expense of other programs or taxpayers nationwide.

  • Increased Federal Spending: Reclassification inflates the federal share of Medicaid expansion costs.
  • Distorted Program Evaluations: It obscures the true impact and cost-effectiveness of Medicaid expansion.
  • Potential for Abuse: It creates opportunities for states to manipulate enrollment numbers for financial gain.
AI Search Multiple angles on this topic

The Medi-Cal Case Study

Recent state-focused reviews highlight California's Medicaid program, known as Medi-Cal, with dedicated guides covering eligibility, income limits, how to apply, and coverage details. As the source reports, prospective enrollees must satisfy state-set criteria that can differ meaningfully from federal baseline standards, illustrating the ACA's decision to leave expansion design partly in state hands. California is frequently held up as an example of an aggressive expansion, but a review focused on a single state should not be generalized to the rest of the country. The practical, step-by-step framing of such guides reflects the broader research landscape, where each state publishes its own eligibility and enrollment guidance and comparisons across states remain inherently uneven.

When Flexibility Becomes a Flashpoint

Not all assessments of state behavior under the Affordable Care Act are critical, and proponents of the current design argue that state flexibility is a feature rather than a flaw. From this perspective, differences in eligibility, outreach, and enrollment among states reflect legitimate local choices about budgets and priorities rather than deliberate gaming. At the same time, critics point to real failures in the system, including uneven coverage, administrative churn, and gaps left where states declined or narrowly tailored expansion. Both readings rest on the same underlying fact: without standardized federal enforcement, the line between allowable flexibility and strategic exploitation is difficult to draw, and the evidence allows for more than one interpretation.

State-by-State Divergence

Comparing Medicaid expansion across states reveals substantial divergence, with some states adopting broad expansion, some pursuing partial or restricted versions, and others opting out entirely. Because funding, eligibility, and benefit decisions are made at the state level, enrollment outcomes and coverage quality vary widely even though all programs operate under the same federal statutory umbrella. Such comparisons are inherently difficult to make fairly, since states report data differently and local demographics and health-care markets shape results independently of policy choices. As a result, any comparative analysis of state performance should be read as suggestive rather than definitive, with the differences themselves serving as the clearest finding.

The study highlights that, in many cases, Medicaid enrollees are likely unaware of how they are classified, as the process primarily involves administrative and reimbursement requests. However, the researchers emphasize that these reclassifications had substantial fiscal implications. Their results suggest that the U.S. Treasury bore a significantly higher cost for Medicaid expansion than would have been the case without these reclassifications. From 2014 to 2019, an estimated $52.9 billion in additional federal funding was distributed to states due to reclassification, including $8.3 billion in 2019 alone.

The Road Ahead: Ensuring Accountability and Transparency in Medicaid Funding

The findings of this study underscore the need for greater scrutiny and oversight of Medicaid enrollment practices. As policymakers grapple with rising healthcare costs and debates over the future of the ACA, understanding the incentives that drive state behavior is crucial. More stringent federal monitoring of enrollment practices, along with alternative financing methods, could help mitigate the risk of improper reclassifications and ensure that Medicaid dollars are used effectively and efficiently. By addressing these hidden subsidies, policymakers can promote a more sustainable and equitable healthcare system for all Americans.

AI Search Multiple angles on this topic

Judgment Depends on the Observer

A synthesis of the debate suggests that whether states are gaming the system, or merely exercising authorized discretion, depends heavily on the observer's assumptions about how much uniformity federal programs should enforce. Commentary in this space tends to divide along familiar lines: those who trust state innovation see variation as healthy, while those who prioritize consistency see the same variation as exploitation. What most commentary can agree on is that the ACA's design deliberately delegated consequential choices to states, making questions of intent and abuse inherently difficult to resolve. As such, expert takes should be treated as interpretations of the same structural ambiguity rather than as settled verdicts.

Unresolved Tensions Ahead

Looking forward, the core tension between federal standards and state latitude is unlikely to disappear, and future policy shifts could change the incentive structure states face under expansion. Proposed changes to federal matching rates, work requirements, and reporting obligations would each alter the calculus for state officials deciding how broadly to enroll and retain people. Projections about where these pressures lead remain uncertain, however, because the political and fiscal environment can shift quickly. For those reasons, forward-looking claims about state behavior should be treated as scenarios and speculation rather than established findings.

One Program Inside a Larger System

The expansion debate sits within a broader set of systemic challenges, including rising health-care costs, workforce shortages, and the uneven distribution of coverage across a federalist system. Medicaid's joint funding structure means that state fiscal pressures, federal budget politics, and local health-market conditions all shape who ultimately gets covered. These systemic forces complicate any effort to attribute outcomes solely to state behavior, since external factors drive results independent of policy intent. Viewed this way, the question of gaming is inseparable from the structural design of American health policy itself.

Coverage Decisions Become Lived Reality

Behind the statistics and legal analyses are millions of individuals whose access to care depends on how their state applies expansion rules. Differences in state decisions translate directly into real-world consequences, including whether a low-income adult can see a doctor, receive preventive care, or afford needed treatment. Because these human outcomes flow from administrative and political choices made far from any individual's control, the stakes of the gaming debate are concrete and personal. Still, quantifying these lived impacts precisely is difficult, and accounts of individual experiences often vary from state to state and study to study.

How enrollment and spending are distributed across Medicaid groups

A separate budget analysis associated expansion with lower state spending on traditional Medicaid during 2014–17. That comparison estimates a budget effect under the assumption that traditional Medicaid spending in expansion states would otherwise have tracked spending in nonexpansion states; it is not a direct count of reclassified enrollees.[1]

GAO also reported that provider taxes and local government funds supplied a substantial portion of the nonfederal share of Medicaid payments in state fiscal year 2018, a larger share than a decade earlier. This describes a financing arrangement, not evidence that those funds caused enrollment classifications to change.[2]

What the group totals do and do not show

The enrollment and expenditure totals show that the traditional eligibility group was much larger and accounted for most Medicaid spending in the reported data. They do not, by themselves, establish whether individuals were improperly moved between eligibility groups or explain why spending differed across groups.[3]

The state-budget comparison points to a different consequence of expansion: lower spending on traditional Medicaid at the state level under a stated counterfactual assumption. It cannot by itself distinguish administrative reclassification from other pathways through which expansion could affect budgets.[1]

GAO identified an oversight gap for eligibility decisions made through federally facilitated exchanges in states that delegated those decisions to the federal government. That gap concerns review and matching of expenditures; it does not establish that ineligible people were enrolled.[3]

What evidence could clarify classification and oversight

  • How do eligibility and spending patterns vary among optional eligibility groups and populations covered through Section 1115 waivers? Those pathways contribute to substantial variation in Medicaid eligibility from state to state.[4]
  • What review procedures can verify eligibility and federal matching when determinations are made through federally facilitated exchanges? GAO identified those determinations as outside CMS review in the states that delegated them.[3]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is the Affordable Care Act (ACA) and how did it impact Medicaid?

The Affordable Care Act (ACA), enacted in 2010, significantly altered the healthcare landscape in the United States. A key change was the expansion of Medicaid, the largest source of health insurance in the U.S. The ACA allowed states to extend Medicaid eligibility to non-elderly adults with incomes up to 138% of the federal poverty level. Initially, the federal government covered 100% of the costs for these newly eligible individuals, decreasing to 90% in perpetuity. This expansion aimed to increase healthcare coverage, but it also introduced fiscal incentives that led to unintended consequences, such as Medicaid reclassification.

2

What does Medicaid reclassification mean in the context of the ACA, and why is it a concern?

Medicaid reclassification refers to the practice of states shifting existing Medicaid enrollees into the 'newly eligible' expansion group created by the Affordable Care Act. Because the federal government provides a higher matching rate for the expansion group, states can offload a larger portion of their Medicaid costs to the federal government. This creates a fiscal incentive for reclassification. This is concerning because it inflates the federal share of Medicaid spending, distorts program evaluations, and creates opportunities for states to manipulate enrollment numbers for financial gain. It doesn't directly impact the care received, but it has fiscal implications, potentially affecting taxpayers and other programs.

3

How does Medicaid reclassification affect federal spending, and what are the financial implications?

Medicaid reclassification inflates federal spending on Medicaid expansion. The study found that reclassifications led to substantial additional federal funding for states. From 2014 to 2019, an estimated $52.9 billion in extra federal funds were distributed due to reclassification, with $8.3 billion in 2019 alone. This means the U.S. Treasury bore a significantly higher cost. These reclassifications can inflate the federal cost of Medicaid expansion, potentially diverting resources from other programs and increasing the burden on taxpayers nationwide.

4

Who is aware of the Medicaid reclassification process and what are the key issues identified?

Typically, Medicaid enrollees are likely unaware of the reclassification process, which is primarily handled through administrative and reimbursement requests. However, the researchers highlight that these reclassifications have significant fiscal consequences. The key issues are increased federal spending, distorted program evaluations, and potential for abuse. The practice allows states to draw down more federal funds, which is particularly problematic given the long-term financial sustainability of Medicaid. These issues create an environment where states can manipulate enrollment numbers, potentially at the expense of federal resources intended to expand healthcare access.

5

What steps are being suggested to address the issue of Medicaid reclassification, and what is the road ahead?

The findings underscore the need for greater scrutiny and oversight of Medicaid enrollment practices. The suggestion is for more stringent federal monitoring of enrollment practices and exploring alternative financing methods to mitigate improper reclassifications. Addressing these hidden subsidies could promote a more sustainable and equitable healthcare system. Policymakers must understand the incentives driving state behavior. The focus should be on ensuring that Medicaid dollars are used effectively and efficiently. The road ahead involves greater transparency and accountability in Medicaid funding to ensure the integrity of the system and the responsible use of federal funds.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.